Pak Fah Yeow International Limited (0239.HK)
HKD 2.27
(0.89%)
HKD 2.27
(0.89%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -258.7 Million HKD | -59.82% |
| 2022 | -161.87 Million HKD | -10.59% |
| 2021 | -146.37 Million HKD | -50.33% |
| 2020 | -97.37 Million HKD | -17.08% |
| 2019 | -83.16 Million HKD | 18.58% |
| 2018 | -102.14 Million HKD | -11.04% |
| 2017 | -91.98 Million HKD | -174.22% |
| 2016 | -33.54 Million HKD | -263.73% |
| 2015 | 20.48 Million HKD | -38.42% |
| 2014 | 33.27 Million HKD | -10.81% |
| 2013 | 37.3 Million HKD | 108.05% |
| 2012 | 17.93 Million HKD | -65.7% |
| 2011 | 52.28 Million HKD | 5.32% |
| 2010 | 49.64 Million HKD | 15.83% |
| 2009 | 42.85 Million HKD | -43.68% |
| 2008 | 76.09 Million HKD | 6.66% |
| 2007 | 71.33 Million HKD | 19.67% |
| 2006 | 59.61 Million HKD | -9.14% |
| 2005 | 65.6 Million HKD | 43016.2% |
| 2004 | -152.87 Thousand HKD | -36.67% |
| 2003 | -111.85 Thousand HKD | 98.7% |
| 2002 | -8.61 Million HKD | -36.74% |
| 2001 | -6.29 Million HKD | -113.34% |
| 2000 | 47.2 Million HKD | 213.37% |
| 1999 | 15.06 Million HKD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -348.16 Million HKD | 0.0% |
| 2023 FY | -258.7 Million HKD | -59.82% |
| 2023 Q4 | -258.7 Million HKD | 0.0% |
| 2023 Q2 | -221.9 Million HKD | 0.0% |
| 2022 Q4 | -161.87 Million HKD | 0.0% |
| 2022 Q2 | -155.26 Million HKD | 0.0% |
| 2022 FY | -161.87 Million HKD | -10.59% |
| 2021 Q2 | -133.88 Million HKD | 0.0% |
| 2021 Q4 | -146.37 Million HKD | 0.0% |
| 2021 FY | -146.37 Million HKD | -50.33% |
| 2020 FY | -97.37 Million HKD | -17.08% |
| 2020 Q2 | -97.8 Million HKD | 0.0% |
| 2020 Q4 | -97.37 Million HKD | 0.0% |
| 2019 FY | -83.16 Million HKD | 18.58% |
| 2019 Q4 | -83.16 Million HKD | 0.0% |
| 2019 Q2 | -127.94 Million HKD | 0.0% |
| 2018 FY | -102.14 Million HKD | -11.04% |
| 2018 Q2 | -96.88 Million HKD | 0.0% |
| 2018 Q4 | -104.22 Million HKD | 0.0% |
| 2017 Q4 | -94.06 Million HKD | 0.0% |
| 2017 Q2 | -73.17 Million HKD | 0.0% |
| 2017 FY | -91.98 Million HKD | -174.22% |
| 2016 Q2 | -18.86 Million HKD | 0.0% |
| 2016 Q4 | -35.62 Million HKD | 0.0% |
| 2016 FY | -33.54 Million HKD | -263.73% |
| 2015 FY | 20.48 Million HKD | -38.42% |
| 2015 Q4 | 18.41 Million HKD | 0.0% |
| 2015 Q2 | -7.76 Million HKD | 0.0% |
| 2014 FY | 33.27 Million HKD | -10.81% |
| 2014 Q4 | 33.27 Million HKD | 0.0% |
| 2014 Q2 | 17.89 Million HKD | 0.0% |
| 2013 Q4 | 5.87 Million HKD | 0.0% |
| 2013 FY | 37.3 Million HKD | 108.05% |
| 2013 Q2 | 16.57 Million HKD | 0.0% |
| 2012 Q4 | 17.93 Million HKD | 0.0% |
| 2012 Q2 | 30.72 Million HKD | 0.0% |
| 2012 FY | 17.93 Million HKD | -65.7% |
| 2011 Q2 | 49.95 Million HKD | 0.0% |
| 2011 FY | 52.28 Million HKD | 5.32% |
| 2011 Q4 | 52.28 Million HKD | 0.0% |
| 2010 Q2 | 37.56 Million HKD | 0.0% |
| 2010 Q4 | 49.64 Million HKD | 0.0% |
| 2010 FY | 49.64 Million HKD | 15.83% |
| 2009 Q4 | 42.85 Million HKD | 0.0% |
| 2009 FY | 42.85 Million HKD | -43.68% |
| 2008 FY | 76.09 Million HKD | 6.66% |
| 2007 FY | 71.33 Million HKD | 19.67% |
| 2006 FY | 59.61 Million HKD | -9.14% |
| 2005 FY | 65.6 Million HKD | 43016.2% |
| 2004 FY | -152.87 Thousand HKD | -36.67% |
| 2003 FY | -111.85 Thousand HKD | 98.7% |
| 2002 FY | -8.61 Million HKD | -36.74% |
| 2001 FY | -6.29 Million HKD | -113.34% |
| 2000 FY | 47.2 Million HKD | 213.37% |
| 1999 FY | 15.06 Million HKD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Grand Pharmaceutical Group Limited | 2.03 Billion HKD | 112.732% |
| Extrawell Pharmaceutical Holdings Limited | 5.94 Million HKD | 4452.338% |
| Wai Yuen Tong Medicine Holdings Limited | 301.53 Million HKD | 185.795% |
| Qianhai Health Holdings Limited | -19.03 Million HKD | -1258.877% |
| Lee's Pharmaceutical Holdings Limited | 30.94 Million HKD | 935.928% |
| Essex Bio-Technology Limited | -219.22 Million HKD | -18.006% |
| Tongfang Kontafarma Holdings Limited | 256.16 Million HKD | 200.991% |
| PuraPharm Corporation Limited | 377.54 Million HKD | 168.522% |
| SSY Group Limited | 1.71 Billion HKD | 115.098% |
| JBM (Healthcare) Limited | -7.39 Million HKD | -3396.459% |
| Jacobson Pharma Corporation Limited | 337.44 Million HKD | 176.666% |
| China Resources Pharmaceutical Group Limited | 50.97 Billion HKD | 100.507% |